Search Results

61 - 70 of 281 items :

  • pharmacokinetics x
  • Clinical Medicine x
Clear All
Trends in vascular pharmacology research in the Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University, Bratislava

, Kriška M, Kovalčík V. (1978). Bayliss myogenic response in the isolated ductus arteriosus of guinea-pig and rabbit fetuses. Experientia   34 : 745-746. Turnheim K. (2003). When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol   38 : 843-853. Varga Z, Kriška M, Kristová V, Hudec. (2010). Prescription of NSAIDs and risk of cardiovascular adverse effects in hospitalized patients. Rheumatologia 24 : 87-90. Vojtko R., Villaris R., Petrová M., Líšková S

Open access
Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice

: 384-388. Yamamoto K, Sawada Y and Iga T. (1995). Comparative pharmacokinetics of four cholinesterase inhibitors in rats. Biol Pharm Bull   18 : 1292-1295. Yee D, Rhinebbart-Jones TR and Elkins L. (1996). Loss of either CD4+ or DC8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen Francisella tularensis strain LVS. J Immunol   157 : 5042-5048.

Open access
Effect of stilbene derivative on superoxide generation and enzyme release from human neutrophils in vitro

-90. Perečko T, Drabikova K, Nosaľ R, Harmatha J, Bauerova K, Mihalova D, Jančinova V. (2010 a). Inhibition of oxidant production in rat adjuvant arthritis with pterostilbene. Interdiscip Toxicol 3: A73-74. Remsberg CM,Yanez JA, Ohgami Y,Vega-Villa KR, Rimando AM, Davies NM. (2008). Pharmacometrics of pterostilbene. Preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res 22 : 169-179. Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, Duke SO. (2002). Cancer

Open access
Fifty-Five years of Pediatric Endocrinology and 50 years of the Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases in Slovenia / 55 Let Pediatrične Endokrinologije in 50 Let Kliničnega Oddelka Za Endokrinologijo, Diabetes in Presnovne Bolezni Pediatrične Klinike

-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics. Eur J Endocrinol 2011; 165: 401-9. 5. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J. et al. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 2012; 97: E694-9. 6. Kotnik P, Keuper M, Wabitsch M, Fischer-Posovszky P. Interleukin-1β downregulates RBP4 secretion in human adipocytes. PLoS

Open access
Can a Person with Attention Deficit Hyperactivity Disorder be an Athlete?

-Deficit Hyperactivity Disorder in Athletes, Curr Sports Med Rep. 2011;10(1):32-36. 23. Comiran E, Kessler FH, Fröehlich PE et al - Lisdexamfetamine: A pharmacokinetic review, Eur J Pharm Sci. 2016;89:172–179. 24. Garnock-Jones KP, Keating GM - Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents, Pediatr Drugs. 2009;11(3):203-226. 25. Strange BC– Once-daily treatment of ADHD with guanfacine: patient implications. Neuro psychiatr Dis Treat. 2008;4(3):499-506. 26. Söderlund GBW, Björk C, and Gustafsson P

Open access
Evaluation of Teratogenic Activity of Antiepileptic Drug Lamotrigine in Mouse Fetuses

, Bastaki S, et al. Experimental studies on reproductive toxicologic effects of lamotrigine in mice. Birth Defects Res B Dev Reprod Toxicol 2003; 68(5): 428-38. 30. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000; 41(6): 709-13. 31. Tunbridge EM, Attenburrow MJ, Gardiner A, et al. Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial. Bipolar Disorders 2017; 19(6): 477

Open access
Identification of peptide and protein doping related drug compounds confiscated in Denmark between 2007-2013

[12] Henninge J., Pepaj, M., Hullstein, I., Hemmersbach, P., Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation, Drug Test Analysis., 2010, 2, 647-650 [13] Mock S., Shen, X., Tamvakopoulos, C., Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration, Rapid Commun. Mass Spectrom., 2002, 16, 2142-2147 [14] Tamvakopoulos C., Mass spectrometry for the

Open access
Prophylactic efficacy of some chemoprotectants against abrin induced lethality

. Garg V, Hon YY, Jusko WJ. (1994). Effects of acute and chronic inflammation on the pharmacokinetics of prednisolone in rats. Pharm Res 11 : 541–4. Griffiths GD. (2011). Understanding ricin from a defensive viewpoint. 3 : 1373–92. Kerksick C, Willoughby D. (2005). The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr 9 : 38–44. Kumar O, Sugendran K, Vijayaraghavan R. (2003). Oxidative stress associated hepatic and renal toxicity induced by ricin in mice. Toxicon 41

Open access
Platinum Complexes with Edda (Ethylenediamine -N, N - Diacetate) Ligands as Potential Anticancer Agents

-22. 21. Hamilton, G., & Olszewski, U. (2013). Picoplatin pharmacokinetics and chemotherapy of non-small cell lung cancer. Drug Evaluations. 9(10), 1381-1390. 22. Jakupec, M.A., Galanski, M., & Keppler, B.K. (2003). Tumor inhibiting platinum complexes- state of the art and future perspectives. Rev Physiol Biochem Pharmacol. 146, 1-53. 23. Armand, J.P., Bolgie, V., Raymond, E., Fizazi, K., Faivre, S., & Ducreux, M. (2000). Oxaliplatin in colorectal cancer: an overview. Semin Oncol., 27, 96-104. 24. Kelland, L. (2007). The

Open access
Analysis of benzo[a]pyrene metabolites formed by rat hepatic microsomes using high pressure liquid chromatography: optimization of the method

). Biotransformation, hepatopancreas DNA binding and pharmacokinetics of benzo[a]pyrene after oral and parenteral administration to the American lobster, Homarus americanus. Chem Biol Interact   95 : 141-160. James MO, Altman AH, Morris K, Kleinow KM, Tong Z. (1997). Dietary modulation of phase 1 and phase 2 activities with benzo(a)pyrene and related compounds in the intestine but not the liver of the channel catfish, Ictalurus punctatus. Drug Metab Dispos   25 : 346-354. Jiang H, Gelhaus SL, Mangal D, Harvey RG, Blair IA

Open access